106 related articles for article (PubMed ID: 21839804)
1. Activin and inhibin, estrogens and NFκB, play roles in ovarian tumourigenesis is there crosstalk?
Drummond AE; Fuller PJ
Mol Cell Endocrinol; 2012 Aug; 359(1-2):85-91. PubMed ID: 21839804
[TBL] [Abstract][Full Text] [Related]
2. Mutations in inhibin and activin genes associated with human disease.
Shelling AN
Mol Cell Endocrinol; 2012 Aug; 359(1-2):113-20. PubMed ID: 21827823
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localization of inhibin and activin subunits, activin receptors, and Smads in ovarian clear cell adenocarcinoma.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Oncol Rep; 2006 Feb; 15(2):291-6. PubMed ID: 16391844
[TBL] [Abstract][Full Text] [Related]
4. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
5. Inhibins and activins: their roles in the adrenal gland and the development of adrenocortical tumors.
Hofland J; de Jong FH
Mol Cell Endocrinol; 2012 Aug; 359(1-2):92-100. PubMed ID: 21722704
[TBL] [Abstract][Full Text] [Related]
6. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
Lewis KA; Gray PC; Blount AL; MacConell LA; Wiater E; Bilezikjian LM; Vale W
Nature; 2000 Mar; 404(6776):411-4. PubMed ID: 10746731
[TBL] [Abstract][Full Text] [Related]
7. [Activin and activin receptors in related gynecologic and obstetric diseases].
Li H; Huang F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 35(8):896-902. PubMed ID: 20818087
[TBL] [Abstract][Full Text] [Related]
8. Activins and activin antagonists in the human ovary and ovarian cancer.
Reader KL; Gold E
Mol Cell Endocrinol; 2015 Nov; 415():126-32. PubMed ID: 26277402
[TBL] [Abstract][Full Text] [Related]
9. Molecular biology of inhibin action.
Cook RW; Thompson TB; Jardetzky TS; Woodruff TK
Semin Reprod Med; 2004 Aug; 22(3):269-76. PubMed ID: 15319829
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of alpha-inhibin expression in the fetal ovary of estrogen-suppressed baboons is associated with impaired fetal ovarian folliculogenesis.
Billiar RB; Zachos NC; Burch MG; Albrecht ED; Pepe GJ
Biol Reprod; 2003 Jun; 68(6):1989-96. PubMed ID: 12606324
[TBL] [Abstract][Full Text] [Related]
11. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
12. Activins and activin antagonists in the prostate and prostate cancer.
Gold E; Risbridger G
Mol Cell Endocrinol; 2012 Aug; 359(1-2):107-12. PubMed ID: 21787836
[TBL] [Abstract][Full Text] [Related]
13. The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.
Mabuchi Y; Yamoto M; Minami S; Umesaki N
Oncol Rep; 2006 Aug; 16(2):373-9. PubMed ID: 16820918
[TBL] [Abstract][Full Text] [Related]
14. Evolving roles of activins and inhibins in ovarian cancer pathophysiology.
Evans ET; Horst B; Arend RC; Mythreye K
Am J Physiol Cell Physiol; 2023 Feb; 324(2):C428-C437. PubMed ID: 36622068
[TBL] [Abstract][Full Text] [Related]
15. Inhibins are the major activin ligands expressed during early thymocyte development.
Licona P; Chimal-Monroy J; Soldevila G
Dev Dyn; 2006 Apr; 235(4):1124-32. PubMed ID: 16477644
[TBL] [Abstract][Full Text] [Related]
16. Inhibins and activins in human fetal abnormalities.
Lambert-Messerlian GM; Pinar H; Laprade E; Tantravahi U; Schneyer A; Canick JA
Mol Cell Endocrinol; 2004 Oct; 225(1-2):101-8. PubMed ID: 15451574
[TBL] [Abstract][Full Text] [Related]
17. Loss of betaglycan expression in ovarian cancer: role in motility and invasion.
Hempel N; How T; Dong M; Murphy SK; Fields TA; Blobe GC
Cancer Res; 2007 Jun; 67(11):5231-8. PubMed ID: 17522389
[TBL] [Abstract][Full Text] [Related]
18. Activins and inhibins in endocrine and other tumors.
Risbridger GP; Schmitt JF; Robertson DM
Endocr Rev; 2001 Dec; 22(6):836-58. PubMed ID: 11739336
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of granulosa cell tumours.
Fuller PJ; Chu S; Fikret S; Burger HG
Mol Cell Endocrinol; 2002 May; 191(1):89-96. PubMed ID: 12044922
[TBL] [Abstract][Full Text] [Related]
20. Activins and inhibins in mammalian testis development: new models, new insights.
Barakat B; Itman C; Mendis SH; Loveland KL
Mol Cell Endocrinol; 2012 Aug; 359(1-2):66-77. PubMed ID: 22406273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
